Brief: Quell® Demonstrates Encouraging Clinical Trial Results In Chemotherapy Induced Peripheral Neuropathy (Cipn)
31/05/2023 14:12
May 31 (Reuters) - NeuroMetrix Inc NURO.O :
* QUELL® DEMONSTRATES ENCOURAGING CLINICAL TRIAL RESULTS IN
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY (CIPN)
Source text for Eikon: ID:nGNX9Bb8Wx
Further company coverage: NURO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13